Saurav Chatterjee (@sauravchmd) 's Twitter Profile
Saurav Chatterjee

@sauravchmd

ID: 863944285347082240

calendar_today15-05-2017 02:29:03

1,1K Tweet

373 Takipçi

90 Takip Edilen

Kuldeep Singh MD (@kuldeep1926) 's Twitter Profile Photo

Another #Endo trick. If using Perclose and unsure of closure. Stick in 0.014 wire and put in a 4F micro access catheter and sinch down. Still allows you to take a final angio to ensure artery still open. Society for Vascular Surgery AMP the CLTI Meeting FutureVascSurgeons #medtwitter Endovascular Today #vascular

Another #Endo trick. If using Perclose and unsure of closure. Stick in 0.014 wire and put in a 4F micro access catheter and sinch down.  Still allows you to take a final angio to ensure artery still open. <a href="/VascularSVS/">Society for Vascular Surgery</a> <a href="/AMPSymposium/">AMP the CLTI Meeting</a> <a href="/FutureVascSurgn/">FutureVascSurgeons</a> #medtwitter <a href="/EVToday/">Endovascular Today</a> #vascular
Giuseppe Biondi-Zoccai (@gbiondizoccai) 's Twitter Profile Photo

Don't miss our session at the European Society of Cardiology Congress, entitled Statistics Made Easy, due on 30 August at 10:00 AM on the ESC TV Stage, and featuring lectures on Significance of the p-value: utility, limitations, misuse, and misinterpretation (by by Stuart

Don't miss our session at the European Society of Cardiology Congress, entitled Statistics Made Easy, due on 30 August at 10:00 AM on the ESC TV Stage, and featuring lectures on Significance of the p-value: utility, limitations, misuse, and misinterpretation (by by Stuart
Giuseppe Biondi-Zoccai (@gbiondizoccai) 's Twitter Profile Photo

In a meta-research analysis leveraging 120 mega-trials, meta-analyses of smaller studies showed overall comparable results with mega-trials, but smaller trials published before the mega-trials gave more favorable results than mega-trials. These findings suggest that mega-trials

In a meta-research analysis leveraging 120 mega-trials, meta-analyses of smaller studies  showed overall comparable results with mega-trials, but smaller trials  published before the mega-trials gave more favorable results than mega-trials. These findings suggest that mega-trials
Behnood Bikdeli (@bbikdeli) 's Twitter Profile Photo

🚨🚨Many guidelines exist for Dx & mgmt of #PulmonaryEmbolism #PE We navigate these in a @JACCjournals review. Check the figures! 👇 Bit.ly/4eB6HTa  @brighamresearch #CardioTwitter #Thrombosis Gregory Piazza George Giannakoulas David Jiménez 🇪🇸 Erik Klok CHEST #DrMoores

🚨🚨Many guidelines exist for Dx &amp; mgmt of #PulmonaryEmbolism #PE We navigate these in a @JACCjournals review. Check the figures! 👇
Bit.ly/4eB6HTa  @brighamresearch 

#CardioTwitter #Thrombosis <a href="/GregoryPiazza4/">Gregory Piazza</a> <a href="/GGiannakoulas/">George Giannakoulas</a> <a href="/DJC6998/">David Jiménez 🇪🇸</a> <a href="/Erik_Klok_MD/">Erik Klok</a> <a href="/accpchest/">CHEST</a> #DrMoores
Vladimir Lakhter (@vladlakhter) 's Twitter Profile Photo

On-the-table “Bolus Only” TPA administration for Tx of patients with acute PE. Very excited to have Christian Bichard present the results of our RESCUE-2 Study evaluating the first-in-human results of this novel approach. #TCT2024 PERT Consortium Society for Vascular Medicine | SVM kenneth rosenfield

On-the-table “Bolus Only” TPA administration for Tx of patients with acute PE.  Very excited to have Christian Bichard present the results of our RESCUE-2 Study evaluating the first-in-human results of this novel approach.  #TCT2024 <a href="/PERTConsortium/">PERT Consortium</a> <a href="/SVM_tweets/">Society for Vascular Medicine | SVM</a> <a href="/krosenfieldMD/">kenneth rosenfield</a>
LA McKeown (@lamckeown1) 's Twitter Profile Photo

"There is a small minority of physicians who are doing this right, because they are taking it out in a timely manner." Enrico Ferro, MD Behnood Bikdeli Riyaz Bashir tctmd.com/news/ivc-filte…

Vikas Aggarwal (@vikasaggarwalmd) 's Twitter Profile Photo

While there are no dedicated RCTs for exercise therapy in CTEPH, CTEPH constituted up to 20% of randomized individuals in 5 RCTs of exercise in PH and noted improvement in 6MWD without any adverse events. @bellavanaken pubmed.ncbi.nlm.nih.gov/39550076/

Yan Holtz (@r_graph_gallery) 's Twitter Profile Photo

🚨 Stop chasing the p-value! Increasing your sample size will always yield a significant result. Even for trivial differences. 🎮 I created a little interactive playground to illustrate this issue: react-graph-gallery.com/example/t-test… Always pair p-values with effect sizes!

Behnood Bikdeli (@bbikdeli) 's Twitter Profile Photo

Isolated subsegmental #PE is a notorious Dx. 🙏🙏AHA Science AHA Peripheral Vascular Disease Council The VIVA Foundation we studied ICD10 codes for SSPE & accuracy or radiology reads: 1. Codes are 🚫 2. Radiology reports may need re-adjudication. Great work Sina Rashedi & 🙏🙏 team. Link👇 doi.org/10.1016/j.thro…

Isolated subsegmental #PE is a notorious Dx. 🙏🙏<a href="/AHAScience/">AHA Science</a> <a href="/PVDCouncil/">AHA Peripheral Vascular Disease Council</a> <a href="/VIVAPhysicians/">The VIVA Foundation</a>  we studied ICD10 codes for SSPE &amp; accuracy or radiology reads:
1. Codes are 🚫
2. Radiology reports may need re-adjudication.

Great work <a href="/SinaRsh/">Sina Rashedi</a> &amp; 🙏🙏 team. Link👇
doi.org/10.1016/j.thro…
Davide Capodanno (@dfcapodanno) 's Twitter Profile Photo

Here’s my guide to navigate the #ACC25 trials, coming this weekend and featured in many journals with a (very) high impact factor. 1. WARRIOR = Intensive medical therapy in women with ANOCA/INOCA 2. STRIDE = Semaglutide in type 2 diabetes and peripheral artery disease 3. API-CAT

Here’s my guide to navigate the #ACC25 trials, coming this weekend and featured in many journals with a (very) high impact factor.

1. WARRIOR = Intensive medical therapy in women with ANOCA/INOCA
2. STRIDE = Semaglutide in type 2 diabetes and peripheral artery disease
3. API-CAT
Dr Shariq Shamim (@shariqshamimmd) 's Twitter Profile Photo

Mangesh will be applying for IM residency #Match2026 He is interested in cardiology and he has been presenting his original work in almost all major CV conferences #CardioTwitter. Very talented and hard working kid. Programs will be lucky to have him.

SCAI (@scai) 's Twitter Profile Photo

🃏 We shared some classic dad jokes with #SCAI2025 attendees last week—now it’s your turn! Got a favorite #InterventionalCardiology joke? Drop it in the comments! 💬💫 Douglas Drachman Lyndon Box Andrew M. Goldsweig, MD, MS

SCAI (@scai) 's Twitter Profile Photo

🎥#SCAIRDN Program Chair Tai Kobayashi, discusses program highlights and what to look forward to in the course on June 6 in Houston. Register today to learn how to build an optimal #RDN program and improve hypertension treatment for your patients.🏥 🔗 bit.ly/SCAIRDN2025

Abdulla A. Damluji, MD, PhD (@drdamluji) 's Twitter Profile Photo

Confounders, Effect Modifiers, and Mediators: Dealing With “Third Variables” in Cardiovascular Epidemiology: Circulation 🥸 Epi 101 from PhD times; nice work from the TIMI group. 😱 Few definitions below; always good to understand the difference between these 👇👇👇

Confounders, Effect Modifiers, and Mediators: Dealing With “Third Variables” in Cardiovascular Epidemiology: <a href="/CircAHA/">Circulation</a> 

🥸 Epi 101 from PhD times; nice work from the TIMI group. 

😱 Few definitions below; always good to understand the difference between these 

👇👇👇
Cardiology Fellows at Mount Sinai Morningside (@msmcardsfellows) 's Twitter Profile Photo

Thrilled to share that Mount Sinai Morningside has been ranked in top‑20 hospitals in the United States for Cardiology & Heart Surgery- U.S. News & World Report 2025‑26! 🫀 We are proud to deliver leading cardiovascular care at MSMW and contributing to this national recognition!

Thrilled to share that Mount Sinai Morningside has been ranked in top‑20 hospitals in the United States for Cardiology &amp; Heart Surgery- U.S. News &amp; World Report 2025‑26! 🫀
We are proud to deliver leading cardiovascular care at MSMW and contributing to this national recognition!
Jay Giri (@jaygirimd) 's Twitter Profile Photo

Now in JACC Journals, we cover the economics of transcatheter interventions. This includes: 1) mechanics of facility & doc payment 2) rapidly evolving CV financial landscape 3) novel research on hospital margins 4) future health econ policy shifts jacc.org/doi/10.1016/j.…

Now in <a href="/JACCJournals/">JACC Journals</a>, we cover the economics of transcatheter interventions. This includes: 

1) mechanics of facility &amp; doc payment
2) rapidly evolving CV financial landscape 
3) novel research on hospital margins
4) future health econ policy shifts 

jacc.org/doi/10.1016/j.…
TCTMD (@tctmd) 's Twitter Profile Photo

The MISSION Act has given US veterans more freedom to access healthcare but at the cost of potentially worse CV care when compared with VA facilities. Increasing access is an admirable goal, but may lead to unintended results, according to study co-author Jay Giri.

The MISSION Act has given US veterans more freedom to access healthcare but at the cost of potentially worse CV care when compared with VA facilities. Increasing access is an admirable goal, but may lead to unintended results, according to study co-author <a href="/jaygirimd/">Jay Giri</a>.